It was a tough week for Indian shares as the BSE Sensex fell nearly 3 percent and the Nifty lost 3.3 percent as U.S. Fed chief Bernanke’s suggestion that stimulus measures may be scaled back at one of their next few meetings dented sentiment. Here's a look at the top Sensex losers and gainers. Full Article
For months, markets have been dancing to central bankers' tune, but that may now be changing, writes James Saft. Full Article
Confused while buying stocks? Get buy, sell or hold recommendations from VantageTrade. Full Coverage
Claris in JV with Japan's Otsuka Pharma, Mitsui for drugs biz
MUMBAI (Reuters) - Drugmaker Claris Lifesciences Ltd (CLAI.BO) said on Friday it will form a joint venture with Japan's Otsuka Pharmaceutical Factory and Mitsui & Co Ltd (8031.T) for its medical infusion drugs business in India and emerging countries.
Claris said its board also approved the sale of its infusion business, on a slump basis, to the company's fully-owned unit, Claris Speciality Injectables, which will eventually run the joint venture.
(Reporting by Kaustubh Kulkarni in MUMBAI)
- Tweet this
- Share this
- Digg this